Výsledky vyhledávání - "Paola Della Cioppa"

Intestinal toxicity during induction chemotherapy with cytarabine-based regimens in adult acute myeloid leukemia

Autor: Bruno Rotoli, Marco Rossi, Maria Rosaria Villa, Paola Della Cioppa, Carmine Selleri, Ciro R. Rinaldi, Rosanna Ciancia, Marco Picardi, Andrea Camera, M Volpicelli, Claudia Andretta

Publikováno v: The Hematology Journal. 4:346-350

Background: Cytotoxic regimens used in induction treatments for acute myeloid leukemia (AML) almost always include standard or high-dose cytarabine (Ara-C). During or soon after induction therapy, leukemic patients frequently develop gastroenteric co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3471c666a94058192ab43d1f6681a9f9
https://doi.org/10.1038/sj.thj.6200304

Zobrazit plný text záznamu

Combined use of free light chain and heavy/light chain ratios allow diagnosis and monitoring of patients with monoclonal gammopathies: Experience of a single institute, with three exemplar case reports

Autor: Michele Caraglia, Lucia Mastrullo, Angela Russo, Catello Tommasino, Paola Della Cioppa, Rosanna Cuccurullo, Gabriella Misso, Claudio Carbone, Alfredo Gagliardi, Anna Lucania

Publikováno v: Oncology Letters

Monoclonal gammopathies are characterized by serum monoclonal component (MC) plus an intact immunoglobulin and a free light chain (FLC), or a combination of both. The measurement of FLC with Freelite® is the standard practice recommended by Internat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52ac9aa593349ac22a52f65ac6afea45
http://hdl.handle.net/11591/370499

Zobrazit plný text záznamu

5-Azacytidine in 82 Low/Intermediate-1 IPSS Risk Myelodysplastic Syndromes: Results from the Italian Patient Named Program

5-azacytidine (AZA) significantly prolonged overall survival in higher-risk patients with myelodysplastic syndromes (MDS) in a large, international, randomized, phase III trial (AZA-001). However, data about efficacy and safety of AZA in lower risk M

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db61f4e6bb270f9b0f74a2d2bb9c5bb5
http://hdl.handle.net/11568/127060

Zobrazit plný text záznamu

Incidence of Febrile Episode During Stem Cell Mobilization (SCM) After High Dose Ciclophosphamide Chemotherapy (HD-CTX) and G-CSF (filgrastim or lenograstim) Administration in Multiple Myeloma (MM) Patients: II Interim Evaluation

Autor: Nicola Di Renzo, Marino Brunori, E. Marturano, Giuseppe Irrera, Enrico Orciuolo, Domenico Pastore, Endri Mauro, Paola Della Cioppa, Gabriele Buda, Clotilde Cangialosi, Giuseppe Pietrantuono, Letizia Lombardini, Mario Petrini

Publikováno v: Blood. 112:4135-4135

Introduction: Clinical use of G-CSF in pts with high grade chemotherapy induced neutropenia does not conduce to a reduction of the incidence of febrile episodes (FE). This paradox may be explained by the acquisition of a defective chemotaxis by neutr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c2efac507ceb06b9f262f1ac85cac599
https://doi.org/10.1182/blood.v112.11.4135.4135

Zobrazit plný text záznamu

Intensity of 18Fluorodeoxyglucose Uptake in Positron Emission Tomography Is Associated with Unfavorable Prognostic Factors in Untreated Follicular Lymphoma

Autor: Filomena Oliviero, Secondo Lastoria, Antonio Pinto, Ferdinando Frigeri, Paola Della Cioppa, Giuseppe Lucio Cascini, Anna De Chiara, Maria Luigia Vigliotti

Publikováno v: Blood. 106:1001-1001

Objective: Follicular lymphoma (FL) is the second most frequent type of non-Hodgkin’s lymphoma (NHL) representing 20–25% of all lymphomas worldwide. FDG-PET is currently adopted for staging and monitoring of patients (pts) with Hodgkin’s diseas

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::634718bb64e9a912e355000c855d9d71
https://doi.org/10.1182/blood.v106.11.1001.1001

Zobrazit plný text záznamu

The Impact of Relative Dose Intensity on Response and Survival in a Series of 180 Newly Diagnosed Patients with Hodgkin’s Lymphoma

Autor: Gaetano Corazzelli, Secondo Lastoria, Antonio Pinto, Gino Svanera, Filippo Russo, Gaetana Capobianco, Ferdinando Frigeri, Paola Della Cioppa

Publikováno v: Blood. 106:2671-2671

To improve ABVD results we first developed a protocol which adds G-CSF to the standard ABVD treatment. From March 1997 to May 2004 69 patients with HL were treated with ABVD+G-CSF and 22 with a standard ABVD. Recently we designed a new dose-dense and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::93ef662cca396484b329dbe9bc15f392
https://doi.org/10.1182/blood.v106.11.2671.2671

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání